{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:10:59Z","timestamp":1792300259461,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.cgh.2007.08.012","type":"journal-article","created":{"date-parts":[[2007,11,27]],"date-time":"2007-11-27T09:09:43Z","timestamp":1196154583000},"page":"1447-1453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":140,"title":["Gastrointestinal Symptoms in 342 Patients With Fabry Disease: Prevalence and Response to Enzyme Replacement Therapy"],"prefix":"10.1016","volume":"5","author":[{"given":"Bjoern","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Keshav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2007.08.012_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.97.1.365","article-title":"Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease","volume":"97","author":"Schiffmann","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cgh.2007.08.012_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2007.08.012_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cgh.2007.08.012_bib4","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.cgh.2007.08.012_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.cgh.2007.08.012_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural history of Fabry disease in females in the Fabry Outcome Survey","volume":"43","author":"Deegan","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.cgh.2007.08.012_bib7","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2007.08.012_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry\u2019s disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.08.012_bib9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2362.2004.01424.x","article-title":"Fabry disease: overall effects of agalsidase alfa treatment","volume":"34","author":"Beck","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cgh.2007.08.012_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(01)01312-7","article-title":"Neuropathic pain in Anderson-Fabry disease: pathology and therapeutic options","volume":"429","author":"MacDermot","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cgh.2007.08.012_bib11","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1007\/BF01540061","article-title":"Anorexia, weight loss, and diarrhea as presenting symptoms of angiokeratoma corporis diffusum (Fabry-Anderson\u2019s disease)","volume":"34","author":"Nelis","year":"1989","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2007.08.012_bib12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00042737-200410000-00020","article-title":"Effect of enzyme-replacement therapy on gastrointestinal symptoms in Fabry disease","volume":"16","author":"Hoffmann","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2007.08.012_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1015009210639","article-title":"Assessment of health-related quality-of-life in males with Anderson Fabry Disease before therapeutic intervention","volume":"11","author":"Miners","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.cgh.2007.08.012_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1023\/B:BOLI.0000037342.59612.69","article-title":"Relief of gastrointestinal symptoms under enzyme replacement therapy [corrected] in patients with Fabry disease","volume":"27","author":"Dehout","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.cgh.2007.08.012_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymgme.2005.04.009","article-title":"Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy","volume":"85","author":"Banikazemi","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cgh.2007.08.012_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol: a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.cgh.2007.08.012_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s001120170107","article-title":"Perzentile f\u00fcr den Body-mass-Index f\u00fcr das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben","volume":"149","author":"Kromeyer-Hauschild","year":"2001","journal-title":"Monatsschr Kinderheil"},{"key":"10.1016\/j.cgh.2007.08.012_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/adc.47.251.26","article-title":"Gut lesions in Fabry\u2019s disease without a rash","volume":"47","author":"Flynn","year":"1972","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.cgh.2007.08.012_bib19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/0003-4819-81-5-628","article-title":"Intestinal manifestations of Fabry\u2019s disease","volume":"81","author":"Rowe","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2007.08.012_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.7326\/0003-4819-86-3-315","article-title":"Small bowel perforation in Fabry\u2019s disease","volume":"86","author":"Bryan","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2007.08.012_bib21","first-page":"246","article-title":"Gastrointestinal structure and function in Fabry\u2019s disease","volume":"76","author":"Sheth","year":"1981","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2007.08.012_bib22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.32.5.498","article-title":"Fabry disease: impaired autonomic function","volume":"32","author":"Cable","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.cgh.2007.08.012_bib23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0016-5085(82)80262-X","article-title":"Pathophysiologic and ultrastructural basis for intestinal symptoms in Fabry\u2019s disease","volume":"82","author":"O\u2019Brien","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2007.08.012_bib24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0016-5085(84)80028-1","article-title":"Jejunal diverticulosis with perforation as a complication of Fabry\u2019s disease","volume":"86","author":"Friedman","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2007.08.012_bib25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00006231-199809000-00009","article-title":"Gastrointestinal symptoms and delayed gastric emptying in Fabry\u2019s disease: response to metoclopramide","volume":"19","author":"Argoff","year":"1998","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.cgh.2007.08.012_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/A:1015511908710","article-title":"Quality of life of patients with Fabry disease","volume":"11","author":"Gold","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.cgh.2007.08.012_bib27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3748\/wjg.v10.i5.713","article-title":"An extended assessment of bowel habits in a general population","volume":"10","author":"Bassotti","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2007.08.012_bib28","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1053\/j.gastro.2005.09.071","article-title":"Gender, age, society, culture, and the patient\u2019s perspective in the functional gastrointestinal disorders","volume":"130","author":"Chang","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2007.08.012_bib29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","article-title":"The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents","volume":"162","author":"Ries","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.cgh.2007.08.012_bib30","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1542\/peds.2004-1678","article-title":"Pediatric Fabry disease","volume":"115","author":"Ries","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.cgh.2007.08.012_bib31","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1572-0241.2004.30388.x","article-title":"Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study","volume":"99","author":"Talley","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2007.08.012_bib32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00004479-200504000-00002","article-title":"Concordance between respondent self-reports and medical records for chronic conditions: experience from the Veterans Health Study","volume":"28","author":"Skinner","year":"2005","journal-title":"J Ambul Care Manage"},{"key":"10.1016\/j.cgh.2007.08.012_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archinte.1969.00300170074014","article-title":"Fabry\u2019s disease with hypogammaglobulinemia and without angiokeratomas","volume":"124","author":"Urbain","year":"1969","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2007.08.012_bib34","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mus.10497","article-title":"Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease","volume":"28","author":"Schiffmann","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cgh.2007.08.012_bib35","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/01.WNL.0000118207.84514.40","article-title":"Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy","volume":"62","author":"Hilz","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.cgh.2007.08.012_bib36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/AJP.0b013e318074c986","article-title":"Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy: a retrospective analysis from the Fabry Outcome Survey","volume":"23","author":"Hoffmann","year":"2007","journal-title":"Clin J Pain"},{"key":"10.1016\/j.cgh.2007.08.012_bib37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1023\/B:BOLI.0000009948.86528.72","article-title":"Hearing loss in Fabry disease: the effect of agalsidase alfa replacement therapy","volume":"26","author":"Hajioff","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.cgh.2007.08.012_bib38","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2362.2006.01701.x","article-title":"Agalsidase alpha and hearing in Fabry disease: data from the Fabry Outcome Survey","volume":"36","author":"Hajioff","year":"2006","journal-title":"Eur J Clin Invest"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356507007707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356507007707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:00:40Z","timestamp":1761541240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356507007707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S1542356507007707"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2007.08.012","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal Symptoms in 342 Patients With Fabry Disease: Prevalence and Response to Enzyme Replacement Therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2007.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}